18.70
-0.23 (-1.22%)
| Penutupan Terdahulu | 18.93 |
| Buka | 18.81 |
| Jumlah Dagangan | 18,084 |
| Purata Dagangan (3B) | 63,650 |
| Modal Pasaran | 171,423,648 |
| Harga / Pendapatan (P/E Ke hadapan) | 123.46 |
| Harga / Jualan (P/S) | 1.65 |
| Harga / Buku (P/B) | 30.43 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 May 2026 |
| Margin Keuntungan | -12.48% |
| Margin Operasi (TTM) | -8.88% |
| EPS Cair (TTM) | -1.34 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 26.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 121.96% |
| Nisbah Semasa (MRQ) | 2.77 |
| Aliran Tunai Operasi (OCF TTM) | -1.80 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.01 M |
| Pulangan Atas Aset (ROA TTM) | -4.72% |
| Pulangan Atas Ekuiti (ROE TTM) | -29.22% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | Sanara MedTech Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 0.5 |
| Purata | 0.67 |
|
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 66.47% |
| % Dimiliki oleh Institusi | 10.43% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Stonebridge Wealth Management, Llc | 31 Mar 2026 | 136,899 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |